Close

Ionis Pharmaceuticals (IONS) enters pact with Bicycle Therapeutics (BCYC) aimed at further advancing LICA technology

Go back to Ionis Pharmaceuticals (IONS) enters pact with Bicycle Therapeutics (BCYC) aimed at further advancing LICA technology

Bicycle Therapeutics (BCYC) PT Raised to $40 at Canaccord Genuity

July 15, 2021 7:58 AM EDT

Canaccord Genuity analyst Arlinda Lee raised the price target on Bicycle Therapeutics (NASDAQ: BCYC) to $40.00 (from $36.00) while maintaining a Buy rating.

The analyst commented, "Yesterday, following Ionis Pharmaceuticals' (ION-NASDAQ) exercise of its option to a worldwide exclusive license to transferrin receptor (TfR1) Bicycles... More